Replies to post #104038 on Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

Advaxis will be presenting ADXS-HOT (NSCLC/ADXS-503) combo data with Keytruda this Thursday at 2:15pm at the IASLC 2020 Lung Cancer Targeted Therapies Meeting, Santa Monica, California, February 19-22, 2020.
Will be interesting to see the 1st HOT combo data this week.

Hope that they hit this one out of the ballpark for a welcome change.

[ubmmg]

Reposting. We might get some PR/update this morning. Watching. This could shed some insight as to how HOT is working.
-----------------------------------------------------
Advaxis will be presenting ADXS-HOT (NSCLC/ADXS-503) combo data with Keytruda this Thursday at 2:15pm at the IASLC 2020 Lung Cancer Targeted Therapies Meeting, Santa Monica, California, February 19-22, 2020.
Will be interesting to see the 1st HOT combo data this week.

From Benzinga:
https://finance.yahoo.com/news/week-ahead-biotech-agile-baudax-200332124.html
"Advaxis, Inc. (NASDAQ: ADXS) will present at the IASLC Congress Phase 1 data for ADXS-503 monotherapy as well as combo therapy along with Keytruda in metastatic non-small cell lung cancer (Saturday)."
IASLC site:
https://www.iaslc.org/Conferences-Events/Event-Details/iaslc-2020-lung-cancer-targeted-therapies-meeting
The program:
https://www.iaslc.org/Portals/0/TTLC_2020-E-Program.pdf?ver=2020-02-12-234232-883